Gabapentin Tablet
Product Images NDC 63629-8490

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-8490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph showing mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks, including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows the mean pain score, with Gabapentin showing a decreasing trend compared to placebo.*

FDA Label Image

Figure 2 (Image 02)

A line graph showing mean pain scores over 7 weeks comparing placebo and two doses of gabapentin (1800 mg/day and 2400 mg/day). The x-axis represents weeks, with a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Both gabapentin dose groups show a decrease in pain scores over time compared to placebo.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares Study 1 and Study 2 results, showing percentages of responders for placebo (PBO) and gabapentin (GBP) at various doses (3600 mg for Study 1; 1800 mg and 2400 mg for Study 2). Significance levels (** p < 0.01, *** p < 0.001) are noted above the gabapentin bars.*

FDA Label Image

Image-04 (Image 04)

An illustrated formula calculating creatinine clearance (CLCr), including variables for age, weight, serum creatinine level, and an adjustment factor for female patients (0.85 multiplier). This mathematical formula is presented in a clear, algebraic format.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin showing its molecular arrangement with a cyclohexane ring attached to an aminomethyl and a carboxymethyl group.*

FDA Label Image

Image-09 (Image 09)

A scatter plot showing percentage difference versus daily dose in milligrams for Gabapentin oral tablets. The chart compares results from three studies labeled a, b, and c, across daily doses of approximately 600 mg, 900 mg, 1200 mg, and 1800 mg. Data points for each study are displayed with corresponding symbols and show an increasing trend in percentage difference with higher doses.*

FDA Label Image

Label (Lbl636298490)

Label for Gabapentin Tablets, USP 800 mg oral tablets by Bryant Ranch Prepack. The label includes the NDC 63629-8490-1 and states the package contains 100 tablets. It shows storage instructions at controlled room temperature and mentions child-resistant packaging. The BRP Pharmaceuticals logo is visible at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.